• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平野小体细丝包含肌动蛋白和肌动蛋白相关蛋白。

Hirano body filaments contain actin and actin-associated proteins.

作者信息

Galloway P G, Perry G, Gambetti P

出版信息

J Neuropathol Exp Neurol. 1987 Mar;46(2):185-99. doi: 10.1097/00005072-198703000-00006.

DOI:10.1097/00005072-198703000-00006
PMID:3029338
Abstract

Hirano bodies are eosinophilic, rod-shaped intraneuronal inclusions whose frequency increases with age and with Alzheimer's disease. To investigate their composition and possible relationship to the neuronal cytoskeleton, we employed immunocytochemistry and immunoelectronmicroscopy by using antisera to cytoskeletal proteins. The presence of actin, alpha-actinin, vinculin and tropomyosin was demonstrated diffusely throughout the Hirano body. The presence of these proteins supports the contention that Hirano bodies are derived from an abnormal organization of the neuronal cytoskeleton. The staining of Hirano bodies with fluorescent labelled phalloidin, a probe with a unique affinity for F-actin, indicates that the actin in Hirano bodies is in the F-state. Results of high voltage electron microscopy on 1.0 and 0.5 micron sections confirm the purely filamentous nature of Hirano bodies. These findings suggest that the mechanism of formation of Hirano bodies is different from that of the neurofibrillary tangle, another characteristic intraneuronal inclusion seen in Alzheimer patients.

摘要

Hirano小体是嗜酸性、杆状的神经元内包涵体,其出现频率随年龄增长以及阿尔茨海默病而增加。为了研究其组成以及与神经元细胞骨架的可能关系,我们通过使用针对细胞骨架蛋白的抗血清进行免疫细胞化学和免疫电子显微镜检查。肌动蛋白、α-辅肌动蛋白、纽蛋白和原肌球蛋白在整个Hirano小体内均呈弥漫性显示。这些蛋白质的存在支持了Hirano小体源自神经元细胞骨架异常组织的观点。用对F-肌动蛋白具有独特亲和力的荧光标记鬼笔环肽对Hirano小体进行染色,表明Hirano小体内的肌动蛋白处于F状态。对1.0微米和0.5微米切片进行的高电压电子显微镜检查结果证实了Hirano小体的纯丝状性质。这些发现表明,Hirano小体的形成机制与神经原纤维缠结不同,神经原纤维缠结是在阿尔茨海默病患者中看到的另一种典型的神经元内包涵体。

相似文献

1
Hirano body filaments contain actin and actin-associated proteins.平野小体细丝包含肌动蛋白和肌动蛋白相关蛋白。
J Neuropathol Exp Neurol. 1987 Mar;46(2):185-99. doi: 10.1097/00005072-198703000-00006.
2
The association of actin with Hirano bodies.肌动蛋白与 Hirano 小体的关联。
J Neuropathol Exp Neurol. 1983 Mar;42(2):146-52. doi: 10.1097/00005072-198303000-00004.
3
Hirano bodies contain tau protein.Hirano小体含有tau蛋白。
Brain Res. 1987 Feb 17;403(2):337-40. doi: 10.1016/0006-8993(87)90071-0.
4
Formation of Hirano bodies in Dictyostelium and mammalian cells induced by expression of a modified form of an actin-crosslinking protein.由一种肌动蛋白交联蛋白的修饰形式表达诱导的盘基网柄菌和哺乳动物细胞中 Hirano 小体的形成。
J Cell Sci. 2002 May 1;115(Pt 9):1939-49. doi: 10.1242/jcs.115.9.1939.
5
Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies.海仁小体的半胱天冬酶切割肌动蛋白(断裂肌动蛋白)免疫标记
Neuropathol Appl Neurobiol. 2000 Aug;26(4):342-6. doi: 10.1046/j.1365-2990.2000.00252.x.
6
Formation of Hirano bodies induced by expression of an actin cross-linking protein with a gain-of-function mutation.由具有功能获得性突变的肌动蛋白交联蛋白表达诱导的 Hirano 小体的形成。
Eukaryot Cell. 2003 Aug;2(4):778-87. doi: 10.1128/EC.2.4.778-787.2003.
7
Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.两种肌动蛋白结合蛋白,即肌动蛋白解聚因子和丝切蛋白,与 Hirano 小体有关。
Neuroreport. 1995 Oct 23;6(15):1985-8. doi: 10.1097/00001756-199510010-00008.
8
The presence of FAC1 protein in Hirano bodies.海仁小体中FAC1蛋白的存在。
Neuropathol Appl Neurobiol. 1998 Oct;24(5):359-66. doi: 10.1046/j.1365-2990.1998.00140.x.
9
High molecular weight microtubule-associated proteins bind to actin lattices (Hirano bodies).
Acta Neuropathol. 1988;77(2):168-74. doi: 10.1007/BF00687427.
10
Requirements for Hirano body formation.海氏小体形成的条件。
Eukaryot Cell. 2014 May;13(5):625-34. doi: 10.1128/EC.00044-14. Epub 2014 Mar 14.

引用本文的文献

1
Identification of actin mutants with neurodegenerative disease-like phenotypes via mutagenesis of the actin-ATP interface.通过肌动蛋白 - ATP界面诱变鉴定具有神经退行性疾病样表型的肌动蛋白突变体。
Front Cell Neurosci. 2025 Jun 4;19:1543199. doi: 10.3389/fncel.2025.1543199. eCollection 2025.
2
Role of LIMK1-cofilin-actin axis in dendritic spine dynamics in Alzheimer's disease.LIMK1-丝切蛋白-肌动蛋白轴在阿尔茨海默病树突棘动力学中的作用
Cell Death Dis. 2025 Jun 3;16(1):431. doi: 10.1038/s41419-025-07741-7.
3
Accumulation of F-actin drives brain aging and limits healthspan in Drosophila.
F- 肌动蛋白的积累导致大脑衰老,并限制果蝇的健康寿命。
Nat Commun. 2024 Oct 25;15(1):9238. doi: 10.1038/s41467-024-53389-w.
4
Advanced Glycation End Products-Induced Alzheimer's Disease and Its Novel Therapeutic Approaches: A Comprehensive Review.晚期糖基化终末产物诱导的阿尔茨海默病及其新型治疗方法:综述
Cureus. 2024 May 30;16(5):e61373. doi: 10.7759/cureus.61373. eCollection 2024 May.
5
The Axonal Actin Filament Cytoskeleton: Structure, Function, and Relevance to Injury and Degeneration.轴突肌动蛋白丝细胞骨架:结构、功能及与损伤和变性的关系。
Mol Neurobiol. 2024 Aug;61(8):5646-5664. doi: 10.1007/s12035-023-03879-7. Epub 2024 Jan 13.
6
LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.LIM 激酶,LIMK1 和 LIMK2,是细胞命运的关键节点作用因子:从分子到病理特征。
Cells. 2023 Mar 4;12(5):805. doi: 10.3390/cells12050805.
7
Role of Cofilin in Alzheimer's Disease.丝切蛋白在阿尔茨海默病中的作用。
Front Cell Dev Biol. 2020 Nov 26;8:584898. doi: 10.3389/fcell.2020.584898. eCollection 2020.
8
Cleavage of human tau at Asp421 inhibits hyperphosphorylated tau induced pathology in a Drosophila model.人 Tau 在 Asp421 处的裂解抑制了果蝇模型中过度磷酸化 Tau 诱导的病理。
Sci Rep. 2020 Aug 10;10(1):13482. doi: 10.1038/s41598-020-70423-1.
9
The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease.脂质磷酸酶 Synaptojanin 1 的表达和可溶性发生显著改变,并与阿尔茨海默病的脑损伤有关。
Acta Neuropathol Commun. 2020 Jun 3;8(1):79. doi: 10.1186/s40478-020-00954-1.
10
Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure.阿尔茨海默病中的树突棘:肌动蛋白细胞骨架如何导致突触功能障碍。
Int J Mol Sci. 2020 Jan 30;21(3):908. doi: 10.3390/ijms21030908.